|
Market Closed -
Bombay S.E.
18:02:25 25/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 138.45 INR | -1.56% |
|
+2.33% | +92.59% |
| 09-18 | ZIM Laboratories Limited Incorporates Wholly Owned Subsidiary In Chile | CI |
| 08-08 | ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026 |
| Market Cap | 7.41B 77.35M 67.88M 64.11M 58.42M 109M 110M 767M 297M 3.79B 290M 284M 12.17B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.28B 86.36M 75.78M 71.57M 65.22M 122M 123M 856M 332M 4.23B 324M 317M 13.59B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| 541400 | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.56% | ||
| 1 week | +2.33% | ||
| Current month | +11.97% | ||
| 1 month | +10.27% | ||
| 3 months | +11.79% | ||
| 6 months | +117.62% | ||
| Current year | +92.59% |
| 1 week | 130.35 | 143.2 | |
| 1 month | 112 | 144.85 | |
| Current year | 59.72 | 144.85 | |
| 1 year | 59.72 | 144.85 | |
| 3 years | 59.72 | 144.85 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 01/01/2002 |
| Director of Finance/CFO | - | 01/04/2019 | |
| Director of Finance/CFO | - | 01/01/1991 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 01/01/1990 |
| Director/Board Member | - | 01/01/1991 | |
Prakash Sapkal
BRD | Director/Board Member | - | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.56% | +2.33% | +88.73% | +11.34% | 77.35M | ||
| +0.12% | +0.81% | +16.73% | +64.52% | 46.37B | ||
| +1.09% | +0.36% | +43.72% | +108.13% | 37.26B | ||
| +2.00% | +3.78% | +23.48% | +101.30% | 12.53B | ||
| +0.05% | +0.37% | -6.65% | +20.29% | 11.8B | ||
| 0.00% | 0.00% | +17.65% | +141.86% | 8.97B | ||
| -1.34% | -2.73% | +27.74% | +37.90% | 7.09B | ||
| -2.07% | -2.75% | +20.71% | +212.23% | 7.01B | ||
| +1.43% | +2.22% | +41.73% | -13.30% | 7.29B | ||
| -2.45% | -0.59% | -50.18% | +3.88% | 4.99B | ||
| Average | -0.27% | +0.38% | +22.37% | +68.82% | 14.34B | |
| Weighted average by Cap. | +0.32% | +0.54% | +22.19% | +80.07% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.56M 34.71M 32.78M 29.88M 55.93M 56.33M 392M 152M 1.94B 149M 145M 6.23B | 3.74B 39.06M 34.28M 32.37M 29.5M 55.23M 55.62M 387M 150M 1.91B 147M 143M 6.15B |
| Net income | 122M 1.27M 1.11M 1.05M 959K 1.79M 1.81M 12.59M 4.88M 62.15M 4.77M 4.66M 200M | 58.38M 609K 535K 505K 460K 861K 867K 6.04M 2.34M 29.83M 2.29M 2.24M 95.86M |
| Net Debt | 1.16B 12.08M 10.6M 10.01M 9.12M 17.08M 17.2M 120M 46.39M 591M 45.35M 44.37M 1.9B | 863M 9M 7.9M 7.46M 6.8M 12.73M 12.82M 89.31M 34.59M 441M 33.81M 33.08M 1.42B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | ₹138.45 | -1.56% | 10,677 |
| 24/09/26 | ₹140.65 | +4.53% | 12,704 |
| 23/09/26 | ₹134.55 | +0.64% | 7,657 |
| 22/09/26 | ₹133.70 | -0.19% | 4,678 |
| 21/09/26 | ₹133.95 | -1.00% | 5,345 |
- Stock Market
- Stocks
- 541400 Stock
Select your edition
All financial news and data tailored to specific country editions

















